AVXLAnavex Life Sciences

CSNasdaq (XNAS)·USD

Identity

Security key: 12135
Ticker: AVXL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2006-08-02
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: AVXL

Detail

Enriched 2026-08-14 20:47

Market cap: $316,096,231.22
Shares outstanding (class): 92,671,758
Shares outstanding (weighted): 92,696,842
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 34
Location: NEW YORK, NY
Homepage: https://www.anavex.com
Description: Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Market cap and share counts drift.

Funds holding this security

60 funds · 60 positions · $34.71M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$8.38M	0.00%	2,731,053 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$8.15M	0.11%	2,653,883 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$6.56M	0.01%	2,136,920 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$3.21M	0.00%	1,045,261 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$2.22M	0.02%	724,366 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$2.05M	0.03%	668,447 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$678.9K	0.06%	221,137 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$432.6K	0.01%	140,902 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$369.1K	0.00%	120,223 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$299.0K	0.01%	97,389 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$204.2K	0.02%	66,515 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$180.2K	0.01%	58,700 NS	FIGI
LVIP Franklin Templeton Multi-Factor SMID Cap E… LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$159.4K	0.02%	51,928 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$150.4K	0.00%	48,976 NS	FIGI
EQ/Small Company Index Portfolio EQ Advisors Trust	—	$141.0K	0.01%	45,920 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERAVXL
FIGI_COMPOSITEBBG000C9K8K4
FIGI_SHARE_CLASSBBG001SLQWW6
CIK0001314052
ISINUS0327973006
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Anavex Life Sciences is a clinical-stage biopharmaceutical company developing therapies for neurological disorders, fitting the biotechnology industry under healthcare.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.